The confirmed presence of substandard or falsified anticancer medicines in sub-Saharan Africa will complicate cancer care.

(Alliance News) - Avacta Group PLC on Monday said its lead programme faridoxorubicin showed favourable safety and tolerability in patients with salivary gland cancers.

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For ...

Katy Kell, 71, of Warren, was no stranger to breast cancer. Her family had a history of the disease. Having a mother, sister ...

After Nicole Pettit pulled into her driveway on her return from an appointment with her oncologist, she could see her father waiting for her on the porch, tears in his eyes. Before coming home she ...

AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early ...

Hallmark star Yan-Kay Crystal Lowe is having a hard time thinking about losing her hair to chemo. Here's what she's doing to make it easier.

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

In the study, published Tuesday in the journal The Lancet, researchers analyzed more than 58,000 participants to compare 30 ...

Millions of Americans take antidepressants. And like all medication they come with side effects. Researchers studied 30 ...